GLYXAMBI®

1 / 1
Share this content:

GLYXAMBI® (empagliflozin and linagliptin) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and linagliptin is appropriate.

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters